{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:30:53Z","timestamp":1789428653189,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,5,8]],"date-time":"2017-05-08T00:00:00Z","timestamp":1494201600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,5,8]],"date-time":"2017-05-08T00:00:00Z","timestamp":1494201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"The Chalsty Fund for Breast Cancer","award":["1K12CA457688-O1A1"],"award-info":[{"award-number":["1K12CA457688-O1A1"]}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"crossref","award":["2RO1CA100724"],"award-info":[{"award-number":["2RO1CA100724"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["2P30CA138313"],"award-info":[{"award-number":["2P30CA138313"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s10549-017-4258-9","type":"journal-article","created":{"date-parts":[[2017,5,8]],"date-time":"2017-05-08T05:17:32Z","timestamp":1494220652000},"page":"349-358","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Development of mammary hyperplasia, dysplasia, and invasive ductal carcinoma in transgenic mice expressing the 8p11 amplicon oncogene NSD3"],"prefix":"10.1007","volume":"164","author":[{"given":"Brittany","family":"Turner-Ivey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ericka L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex C.","family":"Rutkovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura S.","family":"Spruill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie N.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4420-8594","authenticated-orcid":false,"given":"Stephen P.","family":"Ethier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,8]]},"reference":[{"issue":"3","key":"4258_CR1","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/(SICI)1098-2264(199807)22:3<186::AID-GCC4>3.0.CO;2-S","volume":"22","author":"J Adelaide","year":"1998","unstructured":"Adelaide J, Chaffanet M, Imbert A, Allione F, Geneix J, Popovici C, van Alewijk D, Trapman J, Zeillinger R, Borresen-Dale AL et al (1998) Chromosome region 8p11-p21: refined mapping and molecular alterations in breast cancer. Genes Chromosomes Cancer 22(3):186\u2013199","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"4258_CR2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1158\/0008-5472.CAN-03-1022","volume":"64","author":"ME Ray","year":"2004","unstructured":"Ray ME, Yang ZQ, Albertson D, Kleer CG, Washburn JG, Macoska JA, Ethier SP (2004) Genomic and expression analysis of the 8p11\u201312 amplicon in human breast cancer cell lines. Cancer Res 64(1):40\u201347","journal-title":"Cancer Res"},{"issue":"6","key":"4258_CR3","doi-asserted-by":"publisher","first-page":"e38575","DOI":"10.1371\/journal.pone.0038575","volume":"7","author":"E Bilal","year":"2012","unstructured":"Bilal E, Vassallo K, Toppmeyer D, Barnard N, Rye IH, Almendro V, Russnes H, Borresen-Dale AL, Levine AJ, Bhanot G et al (2012) Amplified loci on chromosomes 8 and 17 predict early relapse in ER-positive breast cancers. PLoS ONE 7(6):e38575","journal-title":"PLoS ONE"},{"issue":"12","key":"4258_CR4","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1158\/1541-7786.MCR-05-0128","volume":"3","author":"V Gelsi-Boyer","year":"2005","unstructured":"Gelsi-Boyer V, Orsetti B, Cervera N, Finetti P, Sircoulomb F, Rouge C, Lasorsa L, Letessier A, Ginestier C, Monville F et al (2005) Comprehensive profiling of 8p11-12 amplification in breast cancer. Mol Cancer Res 3(12):655\u2013667","journal-title":"Mol Cancer Res"},{"issue":"1","key":"4258_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S0165-4608(99)00007-2","volume":"113","author":"M Carapeti","year":"1999","unstructured":"Carapeti M, Aguiar RC, Watmore AE, Goldman JM, Cross NC (1999) Consistent fusion of MOZ and TIF2 in AML with inv (8) (p11q13). Cancer Genet Cytogenet 113(1):70\u201372","journal-title":"Cancer Genet Cytogenet"},{"issue":"1\u20133","key":"4258_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1006\/geno.2001.6581","volume":"76","author":"I Stec","year":"2001","unstructured":"Stec I, den Dunnen JT (2001) WHSC1L1, on human chromosome 8p11.2, closely resembles WHSC1 and maps to a duplicated region shared with 4p16.3. Genomics 76(1\u20133):5\u20138","journal-title":"Genomics"},{"issue":"22","key":"4258_CR7","doi-asserted-by":"publisher","first-page":"10363","DOI":"10.1158\/0008-5472.CAN-05-1633","volume":"65","author":"M Cully","year":"2005","unstructured":"Cully M, Shiu J, Piekorz RP, Muller WJ, Done SJ, Mak TW (2005) Transforming acidic coiled coil 1 promotes transformation and mammary tumorigenesis. Cancer Res 65(22):10363\u201310370","journal-title":"Cancer Res"},{"issue":"2","key":"4258_CR8","doi-asserted-by":"publisher","first-page":"R23","DOI":"10.1186\/bcr1665","volume":"9","author":"S Elbauomy Elsheikh","year":"2007","unstructured":"Elbauomy Elsheikh S, Green AR, Lambros MB, Turner NC, Grainge MJ, Powe D, Ellis IO, Reis-Filho JS (2007) FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis. Breast Cancer Res 9(2):R23","journal-title":"Breast Cancer Res"},{"issue":"14","key":"4258_CR9","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1038\/sj.onc.1210002","volume":"26","author":"KL Streicher","year":"2007","unstructured":"Streicher KL, Yang ZQ, Draghici S, Ethier SP (2007) Transforming function of the LSM1 oncogene in human breast cancers with the 8p11-12 amplicon. Oncogene 26(14):2104\u20132114","journal-title":"Oncogene"},{"issue":"17","key":"4258_CR10","doi-asserted-by":"publisher","first-page":"7165","DOI":"10.1158\/0008-5472.CAN-08-1360","volume":"68","author":"I Bernard-Pierrot","year":"2008","unstructured":"Bernard-Pierrot I, Gruel N, Stransky N, Vincent-Salomon A, Reyal F, Raynal V, Vallot C, Pierron G, Radvanyi F, Delattre O (2008) Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer. Cancer Res 68(17):7165\u20137175","journal-title":"Cancer Res"},{"issue":"8","key":"4258_CR11","first-page":"2171","volume":"119","author":"J Zhang","year":"2009","unstructured":"Zhang J, Liu X, Datta A, Govindarajan K, Tam WL, Han J, George J, Wong C, Ramnarayanan K, Phua TY et al (2009) RCP is a human breast cancer-promoting gene with Ras-activating function. J Clin Invest 119(8):2171\u20132183","journal-title":"J Clin Invest"},{"issue":"5","key":"4258_CR12","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1101\/gad.1998111","volume":"25","author":"EM Slorach","year":"2011","unstructured":"Slorach EM, Chou J, Werb Z (2011) Zeppo1 is a novel metastasis promoter that represses E-cadherin expression and regulates p120-catenin isoform expression and localization. Genes Dev 25(5):471\u2013484","journal-title":"Genes Dev"},{"key":"4258_CR13","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/1471-2407-12-225","volume":"12","author":"G Wang","year":"2012","unstructured":"Wang G, Liu G, Wang X, Sethi S, Ali-Fehmi R, Abrams J, Zheng Z, Zhang K, Ethier S, Yang ZQ (2012) ERLIN2 promotes breast cancer cell survival by modulating endoplasmic reticulum stress pathways. BMC Cancer 12:225","journal-title":"BMC Cancer"},{"issue":"8","key":"4258_CR14","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.neo.2014.07.007","volume":"16","author":"B Turner-Ivey","year":"2014","unstructured":"Turner-Ivey B, Guest ST, Irish JC, Kappler CS, Garrett-Mayer E, Wilson RC, Ethier SP (2014) KAT6A, a chromatin modifier from the 8p11-p12 amplicon is a candidate oncogene in luminal breast cancer. Neoplasia 16(8):644\u2013655","journal-title":"Neoplasia"},{"issue":"21","key":"4258_CR15","doi-asserted-by":"publisher","first-page":"8487","DOI":"10.1158\/0008-5472.CAN-10-1013","volume":"70","author":"ZQ Yang","year":"2010","unstructured":"Yang ZQ, Liu G, Bollig-Fischer A, Giroux CN, Ethier SP (2010) Transforming properties of 8p11-12 amplified genes in human breast cancer. Cancer Res 70(21):8487\u20138497","journal-title":"Cancer Res"},{"key":"4258_CR16","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.molonc.2016.02.003","volume":"10","author":"JC Irish","year":"2016","unstructured":"Irish JC, Mills JN, Turner-Ivey B, Wilson RC, Guest ST, Rutkovsky A, Dombkowski A, Kappler CS, Hardiman G, Ethier SP (2016) Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ERalpha in SUM-44 breast cancer cells and is associated with ERalpha over-expression in breast cancer. Mol Oncol 10:850\u2013865","journal-title":"Mol Oncol"},{"issue":"1","key":"4258_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1006\/geno.2001.6524","volume":"74","author":"PO Angrand","year":"2001","unstructured":"Angrand PO, Apiou F, Stewart AF, Dutrillaux B, Losson R, Chambon P (2001) NSD3, a new SET domain-containing gene, maps to 8p12 and is amplified in human breast cancer cell lines. Genomics 74(1):79\u201388","journal-title":"Genomics"},{"issue":"27","key":"4258_CR18","doi-asserted-by":"publisher","first-page":"9625","DOI":"10.1073\/pnas.0504126102","volume":"102","author":"G Tonon","year":"2005","unstructured":"Tonon G, Wong KK, Maulik G, Brennan C, Feng B, Zhang Y, Khatry DB, Protopopov A, You MJ, Aguirre AJ et al (2005) High-resolution genomic profiles of human lung cancer. Proc Natl Acad Sci USA 102(27):9625\u20139630","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"4258_CR19","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.cancergencyto.2008.12.008","volume":"190","author":"T Taketani","year":"2009","unstructured":"Taketani T, Taki T, Nakamura H, Taniwaki M, Masuda J, Hayashi Y (2009) NUP98-NSD3 fusion gene in radiation-associated myelodysplastic syndrome with t(8;11) (p11;p15) and expression pattern of NSD family genes. Cancer Genet Cytogenet 190(2):108\u2013112","journal-title":"Cancer Genet Cytogenet"},{"issue":"3","key":"4258_CR20","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.bbrc.2010.06.119","volume":"398","author":"Z Zhou","year":"2010","unstructured":"Zhou Z, Thomsen R, Kahns S, Nielsen AL (2010) The NSD3L histone methyltransferase regulates cell cycle and cell invasion in breast cancer cells. Biochem Biophys Res Commun 398(3):565\u2013570","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"4258_CR21","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.1074\/jbc.M112.426148","volume":"288","author":"C He","year":"2013","unstructured":"He C, Li F, Zhang J, Wu J, Shi Y (2013) The methyltransferase NSD3 has chromatin-binding motifs, PHD5-C5HCH, that are distinct from other NSD (nuclear receptor SET domain) family members in their histone H3 recognition. J Biol Chem 288(7):4692\u20134703","journal-title":"J Biol Chem"},{"issue":"6","key":"4258_CR22","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.molcel.2015.10.033","volume":"60","author":"C Shen","year":"2015","unstructured":"Shen C, Ipsaro JJ, Shi J, Milazzo JP, Wang E, Roe JS, Suzuki Y, Pappin DJ, Joshua-Tor L, Vakoc CR (2015) NSD3-short is an adaptor protein that couples BRD4 to the CHD8 chromatin remodeler. Mol Cell 60(6):847\u2013859","journal-title":"Mol Cell"},{"issue":"5","key":"4258_CR23","doi-asserted-by":"publisher","first-page":"e98293","DOI":"10.1371\/journal.pone.0098293","volume":"9","author":"Y Chen","year":"2014","unstructured":"Chen Y, McGee J, Chen X, Doman TN, Gong X, Zhang Y, Hamm N, Ma X, Higgs RE, Bhagwat SV et al (2014) Identification of druggable cancer driver genes amplified across TCGA datasets. PLoS ONE 9(5):e98293","journal-title":"PLoS ONE"},{"issue":"1","key":"4258_CR24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jmoldx.2016.09.007","volume":"19","author":"J Luo","year":"2017","unstructured":"Luo J, Liu S, Leung S, Gru AA, Tao Y, Hoog J, Ho J, Davies SR, Allred DC, Salavaggione AL et al (2017) An mRNA gene expression-based signature to identify FGFR1-amplified estrogen receptor-positive breast tumors. J Mol Diagn 19(1):147\u2013161","journal-title":"J Mol Diagn"},{"issue":"24","key":"4258_CR25","doi-asserted-by":"publisher","first-page":"11632","DOI":"10.1158\/0008-5472.CAN-06-2946","volume":"66","author":"ZQ Yang","year":"2006","unstructured":"Yang ZQ, Streicher KL, Ray ME, Abrams J, Ethier SP (2006) Multiple interacting oncogenes on the 8p11-p12 amplicon in human breast cancer. Cancer Res 66(24):11632\u201311643","journal-title":"Cancer Res"},{"issue":"1","key":"4258_CR26","doi-asserted-by":"publisher","first-page":"e81843","DOI":"10.1371\/journal.pone.0081843","volume":"9","author":"S Cornen","year":"2014","unstructured":"Cornen S, Guille A, Adelaide J, Addou-Klouche L, Finetti P, Saade MR, Manai M, Carbuccia N, Bekhouche I, Letessier A et al (2014) Candidate luminal B breast cancer genes identified by genome, gene expression and DNA methylation profiling. PLoS ONE 9(1):e81843","journal-title":"PLoS ONE"},{"issue":"13","key":"4258_CR27","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1158\/1078-0432.CCR-13-0190","volume":"19","author":"F Andre","year":"2013","unstructured":"Andre F, Bachelot T, Campone M, Dalenc F, Perez-Garcia JM, Hurvitz SA, Turner N, Rugo H, Smith JW, Deudon S et al (2013) Targeting FGFR with dovitinib (TKI258): preclinical and clinical data in breast cancer. Clin Cancer Res 19(13):3693\u20133702","journal-title":"Clin Cancer Res"},{"issue":"8","key":"4258_CR28","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1158\/2159-8290.CD-15-1246","volume":"6","author":"A Pearson","year":"2016","unstructured":"Pearson A, Smyth E, Babina IS, Herrera-Abreu MT, Tarazona N, Peckitt C, Kilgour E, Smith NR, Geh C, Rooney C et al (2016) High-level clonal FGFR amplification and response to FGFR inhibition in a translational clinical trial. Cancer Discov 6(8):838\u2013851","journal-title":"Cancer Discov"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-017-4258-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-017-4258-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-017-4258-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T12:57:25Z","timestamp":1589720245000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-017-4258-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,8]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["4258"],"URL":"https:\/\/doi.org\/10.1007\/s10549-017-4258-9","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,8]]},"assertion":[{"value":"13 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed. The Institutional Animal Care and Use Committee (IACUC) at the Medical University of SC (MUSC) approved all animal experiments, AR#3397. Male and female WT FVB\/N mice were bred under typical conditions with unlimited access to food and water. Animals were euthanized per IACUC approved protocol during all experiments. This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}